Xuet al. reported that SIRT1 is crucial in mediating the effect of the GLP1 receptoragonist exenatide on ameliorating hepatic steatosis by down-regulatinglipogenic-related protein, including SREBP-1c and PNPLA3 (9). Here, PNPLA3 is linked to fatty liver disease.